Institute of Translational Medicine, Clore Laboratory, University of Buckingham
The Institute of Translational Medicine brings together drug discovery expertise, including chemoinformatics; basic science studies in the areas of obesity, diabetes and metabolic disease; dermatology studies including cancer, bioinformatics and bioimaging.
The institute’s staff has more than 100 years of drug discovery experience in industry and has been at the forefront of drug discovery in the metabolic disease area for decades.
The university is developing a medical school and the first students will enter the MBChB programme in January 2015.
- Profile in Horizon2020 Projects Portal – Issue 7
- Profile in Horizon2020 Projects Portal – Issue 4
- Special Report on www.paneuropeannetworks.com – April 2014
- Profile in Pan European Networks Science – Issue 8
- Profile in Horizon2020projects Portal Preview
- Profile on Horizon2020projects.com
- New molecular targets identification and drug discovery in the areas of diabetes, obesity and cognitive impairment
- Identification of plant based therapies for these disease areas
- Brown adipose tissue and thermogenesis
- Langerhans cell histiocytosis
- Bioimaging, bioinformatics and pathway analysis
- Preservation of pancreatic islet cell mass
Mike Cawthorne
Director of Metabolic Research and Head of Medical School
tel: +44 (0)1280 820309
Clore Laboratory
University of Buckingham
Hunter Street
Buckingham
Buckinghamshire
England
MK18 1EG